Signal active
Organization
Contact Information
Overview
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test. The company combines artificial intelligence with insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing low-cost, multi-cancer blood tests.
About
Biotechnology, Health Care, Health Diagnostics
2018
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Harbinger Health headquartered in United States, North America, operates in the Biotechnology, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $4.6B in funding across 24 round(s). With a team of 101-250 employees, Harbinger Health is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Harbinger Health, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
1
0
$190.0M
Details
2
Harbinger Health has raised a total of $190.0M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2023 | Early Stage Venture | 140.0M | ||
2021 | Early Stage Venture | 50.0M |
Investors
Harbinger Health is funded by 11 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Modi Ventures | - | FUNDING ROUND - Modi Ventures | 140.0M |
Douglas Cole | - | FUNDING ROUND - Douglas Cole | 50.0M |
Harbinger Health | - | FUNDING ROUND - Harbinger Health | 50.0M |
Flagship Pioneering | - | FUNDING ROUND - Flagship Pioneering | 50.0M |
Recent Activity
There is no recent news or activity for this profile.